NewsFDA’s Stricter Regulation of Lab-Developed Tests Faces Lawsuits and Lingering ConcernsAuthor:Liz SzaboPublish date: September 24, 2024Clinical laboratory lobbying groups are suing the FDA over its plans to more strictly regulate lab-developed tests. For now, physicians should see ...Read More
NewsPandemic poses short- and long-term risks to babies, especially boysAuthor:Liz SzaboPublish date: December 22, 2021For fetuses exposed to COVID, the greatest danger is usually not the coronavirus itself, but the mother’s immune system.Read More
NewsPricey precision medicine often financially toxic for cancer patientsAuthor:Liz SzaboPublish date: November 1, 2018Medical treatments targeting the DNA in tumor cells are celebrated, but insurers often won’t cover the skyrocketing cost.Read More
NewsNever too late to operate? Surgery near end of life is common, costlyAuthor:Liz SzaboPublish date: March 1, 2018Nearly 1 in 3 Medicare patients undergo an operation in their final year of life.Read More
NewsCascade of costs could push new gene therapy above $1 million per patientAuthor:Liz SzaboPublish date: October 17, 2017Although Kymriah’s price tag has “shattered oncology drug-pricing norms,” Dr. Saltz said “the sticker price is just the starting point.”Read More
News‘Breakthrough’ leukemia drug also portends ‘quantum leap’ in costAuthor:Liz SzaboPublish date: August 23, 2017Novartis hasn’t announced a price for CTL019, but British health authorities have said a price of $649,000 for a one-time treatment would be justif...Read More
NewsAs government-funded cancer research sags, scientists fear U.S. is ‘losing its edge’Author:Liz SzaboPublish date: June 2, 2017Less and less of the research presented at a prominent cancer conference is supported by the National Institutes of Health, a development that some...Read More
